课题基金 / 基金详情

CLINICAL TRIAL: A PHASE II TRIAL OF POLY-ICLC IN PATIENTS WITH RECURRENT ANAPLAS

CLINICAL TRIAL: A PHASE II TRIAL OF POLY-ICLC IN PATIENTS WITH RECURRENT ANAPLAS
临床试验：POLY-ICLC 在复发性 ANAPLAS 患者中的 II 期试验
批准号：
7717972
负责人：
TIMOTHY CLOUGHESY
金额：
$0.18万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
2007
资助国家：
美国
项目状态：
已结题
起止时间：
2007-12-01 至 2008-11-30
来源：
https://reporter.nih.gov/project-details/7717972
关键词：
Clinical TrialsComputer Retrieval of Information on Scientific Projects DatabaseFundingGliomaGrantInstitutionPatientsPhasePoly ICLCProgression-Free SurvivalsRecurrenceResearchResearch PersonnelResourcesSourceUnited States National Institutes of Health

项目摘要

项目成果

TIMOTHY CLOUGHESY的其他基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 主要目的：以6个月无进展生存期为指标，评价Poly-ICLC治疗复发性间变性胶质瘤的疗效。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Primary objective: To determine the efficacy of Poly-ICLC in patients with recurrent anaplastic glioma as determined by 6 month progression-free survival.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of decorin and diffusion MRI in anti-VEGF efficacy for recurrent glioblastoma
Role of decorin and diffusion MRI in anti-VEGF efficacy for recurrent glioblastoma
Career Enhancement Program
Career Enhancement Program